Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Anti-counterfeit Pharmaceutical Packaging Market, by Region, 2019-2027 (USD Billion)
1.2.2. Anti-counterfeit Pharmaceutical Packaging Market, by Packaging Types, 2019-2027 (USD Billion)
1.2.3. Anti-counterfeit Pharmaceutical Packaging Market, by Technology, 2019-2027 (USD Billion)
1.2.4. Anti-counterfeit Pharmaceutical Packaging Market, by End Use Industries, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Anti-counterfeit Pharmaceutical Packaging Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Anti-counterfeit Pharmaceutical Packaging Market Dynamics
3.1. Anti-counterfeit Pharmaceutical Packaging Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing Packaging industry
3.1.1.2. Increasing government efforts to curb counterfeiting
3.1.2. Market Challenges
3.1.2.1. High Cost of Radio Frequency Identification (RFID)
3.1.2.2. Slow adoption rate.
3.1.3. Market Opportunities
3.1.3.1. Rising healthcare industry in emerging economies.
3.1.3.2. Growing adoption from end use industries.
Chapter 4. Global Anti-counterfeit Pharmaceutical Packaging Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Anti-counterfeit Pharmaceutical Packaging Market, by Packaging Types
6.1. Market Snapshot
6.2. Global Anti-counterfeit Pharmaceutical Packaging Market by Packaging Types, Performance - Potential Analysis
6.3. Global Anti-counterfeit Pharmaceutical Packaging Market Estimates & Forecasts by Packaging Types 2018-2027 (USD Billion)
6.4. Anti-counterfeit Pharmaceutical Packaging Market, Sub Segment Analysis
6.4.1. Bottes & Jars
6.4.2. Vials & Ampoules
6.4.3. Blisters
6.4.4. Trays
6.4.5. Pouches & Sachets
6.4.6. Others (Tubes, Syringes, etc.)
Chapter 7. Global Anti-counterfeit Pharmaceutical Packaging Market, by Technology
7.1. Market Snapshot
7.2. Global Anti-counterfeit Pharmaceutical Packaging Market by Technology, Performance - Potential Analysis
7.3. Global Anti-counterfeit Pharmaceutical Packaging Market Estimates & Forecasts by Packaging Types 2018-2027 (USD Billion)
7.4. Anti-counterfeit Pharmaceutical Packaging Market, Sub Segment Analysis
7.4.1. RFID
7.4.2. Security Inks & Coatings
7.4.3. Security Seals
7.4.4. Holograms
7.4.5. Mass Encryption
7.4.6. Barcode
7.4.7. Mass Serialization
Chapter 8. Global Anti-counterfeit Pharmaceutical Packaging Market, by End Use Industries
8.1. Market Snapshot
8.2. Global Anti-counterfeit Pharmaceutical Packaging Market by End Use Industries, Performance - Potential Analysis
8.3. Global Anti-counterfeit Pharmaceutical Packaging Market Estimates & Forecasts by End Use Industries 2018-2027 (USD Billion)
8.4. Anti-counterfeit Pharmaceutical Packaging Market, Sub Segment Analysis
8.4.1. Pharma & Biological
8.4.2. Medical & Supplies
8.4.3. Gloves
8.4.4. Scissors
8.4.5. Syringes & Needles
8.4.6. Surgical Tapes
8.4.7. Others
8.4.8. Medical Equipment
8.4.9. Surgical
8.4.10. Therapeutic
8.4.11. Diagnostic
Chapter 9. Global Anti-counterfeit Pharmaceutical Packaging Market, Regional Analysis
9.1. Anti-counterfeit Pharmaceutical Packaging Market, Regional Market Snapshot
9.2. North America Anti-Counterfeit Pharmaceutical Packaging Market
9.2.1. U.S. Anti-counterfeit Pharmaceutical Packaging Market
9.2.1.1. Packaging Types breakdown estimates & forecasts, 2018-2027
9.2.1.2. Technology breakdown estimates & forecasts, 2018-2027
9.2.1.3. End Use Industries breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Anti-counterfeit Pharmaceutical Packaging Market
9.3. Europe Anti-counterfeit Pharmaceutical Packaging Market Snapshot
9.3.1. U.K. Anti-counterfeit Pharmaceutical Packaging Market
9.3.2. Germany Anti-counterfeit Pharmaceutical Packaging Market
9.3.3. France Anti-counterfeit Pharmaceutical Packaging Market
9.3.4. Spain Anti-counterfeit Pharmaceutical Packaging Market
9.3.5. Italy Anti-counterfeit Pharmaceutical Packaging Market
9.3.6. Rest of Europe Anti-counterfeit Pharmaceutical Packaging Market
9.4. Asia-Pacific Anti-counterfeit Pharmaceutical Packaging Market Snapshot
9.4.1. China Anti-counterfeit Pharmaceutical Packaging Market
9.4.2. India Anti-counterfeit Pharmaceutical Packaging Market
9.4.3. Japan Anti-counterfeit Pharmaceutical Packaging Market
9.4.4. Australia Anti-counterfeit Pharmaceutical Packaging Market
9.4.5. South Korea Anti-counterfeit Pharmaceutical Packaging Market
9.4.6. Rest of Asia Pacific Anti-counterfeit Pharmaceutical Packaging Market
9.5. Latin America Anti-counterfeit Pharmaceutical Packaging Market Snapshot
9.5.1. Brazil Anti-counterfeit Pharmaceutical Packaging Market
9.5.2. Mexico Anti-counterfeit Pharmaceutical Packaging Market
9.6. Rest of The World Anti-counterfeit Pharmaceutical Packaging Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. RealTag
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Avery Dennison Corporation (U.S.),
10.2.3. CCL Industries Inc. (Canada),
10.2.4. 3M Company (U.S.),
10.2.5. DuPont. (U.S.),
10.2.6. AlpVision S.A (Switzerland),
10.2.7. Zebra Technologies Corporation (U.S.),
10.2.8. SICPA Holding SA (Switzerland),
10.2.9. Applied DNA Sciences Inc. (US),
10.2.10. SAVI Technology, Inc. (U.S.),
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption